Literature DB >> 16641268

In vivo interactions of ecotropic and polytropic murine leukemia viruses in mixed retrovirus infections.

Leonard H Evans1, Marc Lavignon, Karin Peterson, Kim Hasenkrug, Shelly Robertson, Frank Malik, Kimmo Virtaneva.   

Abstract

Mixed retrovirus infections are the rule rather than the exception in mice and other species, including humans. Interactions of retroviruses in mixed infections and their effects on disease induction are poorly understood. Upon infection of mice, ecotropic retroviruses recombine with endogenous proviruses to generate polytropic viruses that utilize different cellular receptors. Interactions among the retroviruses of this mixed infection facilitate disease induction. Using mice infected with defined mixtures of the ecotropic Friend murine leukemia virus (F-MuLV) and different polytropic viruses, we demonstrate several dramatic effects of mixed infections. Remarkably, inoculation of F-MuLV with polytropic MuLVs completely suppressed the generation of new recombinant viruses and dramatically altered disease induction. Co-inoculation of F-MuLV with one polytropic virus significantly lengthened survival times, while inoculation with another polytropic MuLV induced a rapid and severe neurological disease. In both instances, the level of the polytropic MuLV was increased 100- to 1,000-fold, whereas the ecotropic MuLV level remained unchanged. Surprisingly, nearly all of the polytropic MuLV genomes were packaged within F-MuLV virions (pseudotyped) very soon after infection. At this time, only a fractional percentage of cells in the mouse were infected by either virus, indicating that the co-inoculated viruses had infected the same small subpopulation of susceptible cells. The profound amplification of polytropic MuLVs in coinfected mice may be facilitated by pseudotyping or, alternatively, by transactivation of the polytropic virus in the coinfected cells. This study illustrates the complexity of the interactions between components of mixed retrovirus infections and the dramatic effects of these interactions on disease processes.

Entities:  

Mesh:

Year:  2006        PMID: 16641268      PMCID: PMC1472087          DOI: 10.1128/JVI.80.10.4748-4757.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses.

Authors:  David L Wensel; Weihua Li; James M Cunningham
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Detection and quantitation of phenotypically mixed viruses: mixing of ecotropic and xenotropic murine leukemia viruses.

Authors:  A Ishimoto; J W Hartley; W P Rowe
Journal:  Virology       Date:  1977-09       Impact factor: 3.616

3.  Friend and Moloney murine leukemia viruses specifically recombine with different endogenous retroviral sequences to generate mink cell focus-forming viruses.

Authors:  L H Evans; M W Cloyd
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells.

Authors:  A Rein
Journal:  Virology       Date:  1982-07-15       Impact factor: 3.616

5.  Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.

Authors:  B Chesebro; K Wehrly; M Cloyd; W Britt; J Portis; J Collins; J Nishio
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

6.  Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses.

Authors:  M Sitbon; J Nishio; K Wehrly; D Lodmell; B Chesebro
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

7.  Analysis of two strains of Friend murine leukemia viruses differing in ability to induce early splenomegaly: lack of relationship with generation of recombinant mink cell focus-forming viruses.

Authors:  M Sitbon; L Evans; J Nishio; K Wehrly; B Chesebro
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

8.  Two separate envelope regions influence induction of brain disease by a polytropic murine retrovirus (FMCF98).

Authors:  K J Hasenkrug; S J Robertson; J Porti; F McAtee; J Nishio; B Chesebro
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  Co-infection with HIV-1/HTLV-II and the risk of progression to AIDS and death. The Oslo HIV Cohort Study Group.

Authors:  A Eskild; H H Samdal; B Heger
Journal:  APMIS       Date:  1996-09       Impact factor: 3.205

10.  Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat.

Authors:  B K Brightman; Q X Li; D J Trepp; H Fan
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

View more
  4 in total

1.  Inhibition of Borna disease virus replication by an endogenous bornavirus-like element in the ground squirrel genome.

Authors:  Kan Fujino; Masayuki Horie; Tomoyuki Honda; Dana K Merriman; Keizo Tomonaga
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

2.  Profound amplification of pathogenic murine polytropic retrovirus release from coinfected cells.

Authors:  Kyle Rosenke; Marc Lavignon; Frank Malik; Angelo Kolokithas; Duncan Hendrick; Kimmo Virtaneva; Karin Peterson; Leonard H Evans
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

3.  Endogenous retroviruses mobilized during friend murine leukemia virus infection.

Authors:  Stefano Boi; Kyle Rosenke; Ethan Hansen; Duncan Hendrick; Frank Malik; Leonard H Evans
Journal:  Virology       Date:  2016-09-19       Impact factor: 3.616

4.  Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line.

Authors:  Janet W Hartley; Leonard H Evans; Kim Y Green; Zohreh Naghashfar; Alfonso R Macias; Patricia M Zerfas; Jerrold M Ward
Journal:  Retrovirology       Date:  2008-01-04       Impact factor: 4.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.